Global Blood Testing Market Outlook (2014-2022)

July 2015 | 92 pages | ID: G421CF1C69EEN
Stratistics Market Research Consulting

Abstracts

The Global Blood Testing Market is valued at $50.35 billion in 2014 with CAGR of 2.35% is expected to reach $60.59 billion by 2022. Some of the key factors influencing the market growth are increasing diseases, aging population and also increase in demand for point of care testing (POCT). However, lack of awareness and unavailability of skilled labor are likely to restraint the market growth. Technical advancement and innovation in developing new equipment and tools is also driving the market growth.

The Global Blood Testing Market is segmented on the basis of technology, type, end user and geography. On the basis of technology, the market is segmented into Chemiluminescent immunoassay(CLIA), Radio immunoprecipitation assay(RIPA), Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR), Transcription-mediated Amplification (TMA) and Immunofluorescence Assay (IFA). On the basis of type, the market is segmented into Complete Blood Count (CBC), Basic Metabolic Panel (BMP) and Erythrocyte Sedimentation Rate (ESR) and Tabletop OCT devices.The market is divided on the basis of end user into hospitals and clinics, diagnostic centers and homes. Global Blood Testing Market by geography is segmented into North America, Europe, Asia Pacific, and Rest of the World.

The key players in Global Blood Testing Market are Abbott Laboratories, Ortho Clinical Diagnostics, Bio-Rad Laboratories, Baxter International, Gen-Probe Inc., Novartis Diagnostics, Roche Diagnostics, Becton Dickinson & Company, Biomerica Inc., bioMerieux Inc. and Cepheid Corporation.

WHAT OUR REPORT OFFERS:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL BLOOD TESTING MARKET, BY TECHNOLOGY

5.1 Chemiluminescent immunoassay (CLIA)
5.2 Radioimmunoprecipitation assay (RIPA)
5.3 Enzyme-Linked Immunosorbent Assay (ELISA)
5.4 Transcription-mediated Amplification (TMA)
5.5 Immunofluorescence Assay (IFA)
5.6 Polymerase Chain Reaction (PCR)

6 GLOBAL BLOOD TESTING MARKET, BY TYPE

6.1 Basic Metabolic Panel (BMP)
6.2 Complete Blood Count (CBC)
6.3 Erythrocyte Sedimentation Rate (ESR)
6.4 Tabletop OCT devices

7 GLOBAL BLOOD TESTING MARKET, BY END USER

7.1 Hospitals and clinics
7.2 Diagnostic centers
7.3 Homes

8 GLOBAL BLOOD TESTING MARKET, BY GEOGRAPHY

8.1 North America
  8.1.1 US
  8.1.2 Canada
8.2 Europe
  8.2.1 Germany
  8.2.2 France
  8.2.3 Italy
  8.2.4 UK
  8.2.5 Spain
8.3 Asia
  8.3.1 Japan
  8.3.2 China
  8.3.3 India
  8.3.4 Australia
  8.3.5 New Zealand
  8.3.6 Rest of Asia
8.4 Rest of the World
  8.4.1 Latin America
  8.4.2 Middle East
  8.4.3 Africa
  8.4.4 Others

9 KEY DEVELOPMENTS

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 COMPANY PROFILING

10.1 Abbott Laboratories
10.2 Ortho Clinical Diagnostics
10.3 Bio-Rad Laboratories
10.4 Baxter International
10.5 Gen-Probe Inc
10.6 Novartis Diagnostics
10.7 Roche Diagnostics
10.8 Becton Dickinson & Company
10.9 Biomerica Inc
10.1 bioMerieux Inc

List Of Tables

LIST OF TABLES

1 Global Blood Testing Market Outlook, By Technology (2012-2022) ($MN)
2 Global Blood Testing Market Outlook, By Chemiluminescent immunoassay (CLIA) (2012-2022) ($MN)
3 Global Blood Testing Market Outlook, By Radioimmunoprecipitation assay (RIPA) (2012-2022) ($MN)
4 Global Blood Testing Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2012-2022) ($MN)
5 Global Blood Testing Market Outlook, By Transcription-mediated Amplification (TMA) (2012-2022) ($MN)
6 Global Blood Testing Market Outlook, By Polymerase Chain Reaction (PCR) (2012-2022) ($MN)
7 Global Blood Testing Market Outlook, By Immunofluorescence Assay (IFA) (2012-2022) ($MN)
8 Global Blood Testing Market Outlook, By Type (2012-2022) ($MN)
9 Global Blood Testing Market Outlook, By Basic Metabolic Panel (BMP) (2012-2022) ($MN)
10 Global Blood Testing Market Outlook, By Complete Blood Count (CBC) (2012-2022) ($MN)
11 Global Blood Testing Market Outlook, By Erythrocyte Sedimentation Rate (ESR) (2012-2022) ($MN)
12 Global Blood Testing Market Outlook, By Tabletop OCT devices (2012-2022) ($MN)
13 Global Blood Testing Market Outlook, By End user (2012-2022) ($MN)
14 Global Blood Testing Market Outlook, By Hospitals and clinics (2012-2022) ($MN)
15 Global Blood Testing Market Outlook, By Diagnostic centers (2012-2022) ($MN)
16 Global Blood Testing Market Outlook, By Home (2012-2022) ($MN)
17 North America Blood Testing Market Outlook, By Technology (2012-2022) ($MN)
18 North America Blood Testing Market Outlook, By Chemiluminescent immunoassay (CLIA) (2012-2022) ($MN)
19 North America Blood Testing Market Outlook, By Radioimmunoprecipitation assay (RIPA) (2012-2022) ($MN)
20 North America Blood Testing Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2012-2022) ($MN)
21 North America Blood Testing Market Outlook, By Transcription-mediated Amplification (TMA) (2012-2022) ($MN)
22 North America Blood Testing Market Outlook, By Polymerase Chain Reaction (PCR) (2012-2022) ($MN)
23 North America Blood Testing Market Outlook, By Immunofluorescence Assay (IFA) (2012-2022) ($MN)
24 North America Blood Testing Market Outlook, By Type (2012-2022) ($MN)
25 North America Blood Testing Market Outlook, By Basic Metabolic Panel (BMP) (2012-2022) ($MN)
26 North America Blood Testing Market Outlook, By Complete Blood Count (CBC) (2012-2022) ($MN)
27 North America Blood Testing Market Outlook, By Erythrocyte Sedimentation Rate (ESR) (2012-2022) ($MN)
28 North America Blood Testing Market Outlook, By Tabletop OCT devices (2012-2022) ($MN)
29 North America Blood Testing Market Outlook, By End user (2012-2022) ($MN)
30 North America Blood Testing Market Outlook, By Hospitals and clinics (2012-2022) ($MN)
31 North America Blood Testing Market Outlook, By Diagnostic centers (2012-2022) ($MN)
32 North America Blood Testing Market Outlook, By Home (2012-2022) ($MN)
33 Europe Blood Testing Market Outlook, By Technology (2012-2022) ($MN)
34 Europe Blood Testing Market Outlook, By Chemiluminescent immunoassay (CLIA) (2012-2022) ($MN)
35 Europe Blood Testing Market Outlook, By Radioimmunoprecipitation assay (RIPA) (2012-2022) ($MN)
36 Europe Blood Testing Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2012-2022) ($MN)
37 Europe Blood Testing Market Outlook, By Transcription-mediated Amplification (TMA) (2012-2022) ($MN)
38 Europe Blood Testing Market Outlook, By Polymerase Chain Reaction (PCR) (2012-2022) ($MN)
39 Europe Blood Testing Market Outlook, By Immunofluorescence Assay (IFA) (2012-2022) ($MN)
40 Europe Blood Testing Market Outlook, By Type (2012-2022) ($MN)
41 Europe Blood Testing Market Outlook, By Basic Metabolic Panel (BMP) (2012-2022) ($MN)
42 Europe Blood Testing Market Outlook, By Complete Blood Count (CBC) (2012-2022) ($MN)
43 Europe Blood Testing Market Outlook, By Erythrocyte Sedimentation Rate (ESR) (2012-2022) ($MN)
44 Europe Blood Testing Market Outlook, By Tabletop OCT devices (2012-2022) ($MN)
45 Europe Blood Testing Market Outlook, By End user (2012-2022) ($MN)
46 Europe Blood Testing Market Outlook, By Hospitals and clinics (2012-2022) ($MN)
47 Europe Blood Testing Market Outlook, By Diagnostic centers (2012-2022) ($MN)
48 Europe Blood Testing Market Outlook, By Home (2012-2022) ($MN)
49 Asia Pacific Blood Testing Market Outlook, By Technology (2012-2022) ($MN)
50 Asia Pacific Blood Testing Market Outlook, By Chemiluminescent immunoassay (CLIA) (2012-2022) ($MN)
51 Asia Pacific Blood Testing Market Outlook, By Radioimmunoprecipitation assay (RIPA) (2012-2022) ($MN)
52 Asia Pacific Blood Testing Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2012-2022) ($MN)
53 Asia Pacific Blood Testing Market Outlook, By Transcription-mediated Amplification (TMA) (2012-2022) ($MN)
54 Asia Pacific Blood Testing Market Outlook, By Polymerase Chain Reaction (PCR) (2012-2022) ($MN)
55 Asia Pacific Blood Testing Market Outlook, By Immunofluorescence Assay (IFA) (2012-2022) ($MN)
56 Asia Pacific Blood Testing Market Outlook, By Type (2012-2022) ($MN)
57 Asia Pacific Blood Testing Market Outlook, By Basic Metabolic Panel (BMP) (2012-2022) ($MN)
58 Asia Pacific Blood Testing Market Outlook, By Complete Blood Count (CBC) (2012-2022) ($MN)
59 Asia Pacific Blood Testing Market Outlook, By Erythrocyte Sedimentation Rate (ESR) (2012-2022) ($MN)
60 Asia Pacific Blood Testing Market Outlook, By Tabletop OCT devices (2012-2022) ($MN)
61 Asia Pacific Blood Testing Market Outlook, By End user (2012-2022) ($MN)
62 Asia Pacific Blood Testing Market Outlook, By Hospitals and clinics (2012-2022) ($MN)
63 Asia Pacific Blood Testing Market Outlook, By Diagnostic centers (2012-2022) ($MN)
64 Asia Pacific Blood Testing Market Outlook, By Home (2012-2022) ($MN)
65 Rest Of The World Blood Testing Market Outlook, By Technology (2012-2022) ($MN)
66 Rest Of The World Blood Testing Market Outlook, By Chemiluminescent immunoassay (CLIA) (2012-2022) ($MN)
67 Rest Of The World Blood Testing Market Outlook, By Radioimmunoprecipitation assay (RIPA) (2012-2022) ($MN)
68 Rest Of The World Blood Testing Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2012-2022) ($MN)
69 Rest Of The World Blood Testing Market Outlook, By Transcription-mediated Amplification (TMA) (2012-2022) ($MN)
70 Rest Of The World Blood Testing Market Outlook, By Polymerase Chain Reaction (PCR) (2012-2022) ($MN)
71 Rest Of The World Blood Testing Market Outlook, By Immunofluorescence Assay (IFA) (2012-2022) ($MN)
72 Rest Of The World Blood Testing Market Outlook, By Type (2012-2022) ($MN)
73 Rest Of The World Blood Testing Market Outlook, By Basic Metabolic Panel (BMP) (2012-2022) ($MN)
74 Rest Of The World Blood Testing Market Outlook, By Complete Blood Count (CBC) (2012-2022) ($MN)
75 Rest Of The World Blood Testing Market Outlook, By Erythrocyte Sedimentation Rate (ESR) (2012-2022) ($MN)
76 Rest Of The World Blood Testing Market Outlook, By Tabletop OCT devices (2012-2022) ($MN)
77 Rest Of The World Blood Testing Market Outlook, By End user (2012-2022) ($MN)
78 Rest Of The World Blood Testing Market Outlook, By Hospitals and clinics (2012-2022) ($MN)
79 Rest Of The World Blood Testing Market Outlook, By Diagnostic centers (2012-2022) ($MN)
80 Rest Of The World Blood Testing Market Outlook, By Home (2012-2022) ($MN)